Published in J Natl Cancer Inst on March 01, 1976
Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One (2008) 1.70
Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect Immun (2006) 1.15
Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med (2014) 1.12
Space-time clustering of Burkitt's lymphoma in the West Nile district of Uganda: 1961-1975. Br J Cancer (1978) 1.10
The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis (2011) 0.98
Further studies of space-time clustering of Burkitt's lymphoma in Uganda. Br J Cancer (1977) 0.92
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med (2015) 0.87
Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One (2012) 0.84
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease. Br J Haematol (2012) 0.81
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal. Adv Hematol (2011) 0.80
Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice. Gend Med (2008) 0.79
Gonadal steroids negatively modulate oxidative stress in CBA/Ca female mice infected with P. berghei ANKA. Biomed Res Int (2014) 0.75
T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: hypothesis. Infect Agent Cancer (2007) 0.75
Denis Burkitt and the African lymphoma. Ecancermedicalscience (2009) 0.75
Familial Burkitt's lymphoma in Papua New Guinea. Br J Cancer (1997) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. Lancet (2000) 8.47
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Mortality of workers at the Sellafield plant of British Nuclear Fuels. Br Med J (Clin Res Ed) (1986) 4.94
Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93
Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health (1996) 4.88
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Carboxyhaemoglobin levels in smokers of filter and plain cigarettes. Lancet (1977) 4.22
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis (2000) 4.06
Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet (1987) 4.01
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg (1986) 3.54
Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet (1984) 3.54
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35
Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99
Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol (1984) 2.96
Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94
Applying burden of disease methods in developing countries: a case study from Pakistan. Am J Public Health (2000) 2.93
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol (1988) 2.91
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
A method of analysis of a certain class of experiments in carcinogenesis. Biometrics (1966) 2.86
Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS (1990) 2.83
Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ (1997) 2.71
Association between atherosclerotic diseases and carboxyhaemoglobin levels in tobacco smokers. Br Med J (1973) 2.62
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) (1982) 2.46
The long-term prognosis of severe infantile malnutrition. Lancet (1967) 2.44
Clinical trial of malaria prophylaxis in tropical splenomegaly syndrome. Br Med J (1971) 2.44
Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43
Toward the primary prevention of cancer. Science (1991) 2.41
Methyldopa liver damage. Br Med J (1974) 2.40
Community-based intervention trials. J Biosoc Sci Suppl (1989) 2.40
The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol (1984) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics (1978) 2.32
Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15
Measuring the burden of disease: healthy life-years. Am J Public Health (1998) 2.12
Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968-1976: evidence of an increasing incidence. Diabetologia (1983) 2.12
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol (1976) 2.11
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. Biometrics (1968) 2.06
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet (1973) 2.02
Chemoattractant receptors on phagocytic cells. Annu Rev Immunol (1984) 2.01
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99
Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet (2001) 1.97
An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya. Int J Epidemiol (1998) 1.96
Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med (1977) 1.94
Use of carboxyhaemoglobin levels to predict the development of diseases associated with cigarette smoking. Thorax (1975) 1.93
The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg (1986) 1.90
Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89
Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (1992) 1.87
Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Slow mortality rate accelerations during aging in some animals approximate that of humans. Science (1990) 1.86
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
Long survivals in acute leukaemia. Lancet (1973) 1.85
Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res (1993) 1.82
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet (1998) 1.81
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer (1991) 1.81
Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol (1977) 1.81
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
An inhibitor of macrophage chemotaxis produced by neoplasms. Science (1976) 1.79
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Vitamin A supplementation and childhood malaria in northern Ghana. Am J Clin Nutr (1995) 1.76
Infant feeding and deaths due to diarrhea. A case-control study. Am J Epidemiol (1989) 1.70